Abstract. Neuroblastoma is an aggressive pediatric tumor that accounts for 15% of cancer-related deaths in children. More than half of high-risk neuroblastoma patients develop tumor relapse that is lethal in most cases. A small population of tumor-initiating cells (TICs), recently identified from high-risk neuroblastoma patients as spheres, is believed to be responsible for tumor relapse. Rab family small G proteins are essential in controlling membrane traffic and their misregulation results in several cancers. Rab15 was originally isolated as a brain-specific Rab protein regulating the endocytic recycling pathway and was recently identified as a downstream target of the neural transcription factor Atoh1. Previously, we identified two alternatively spliced Rab15 isoforms in neuroblastoma cells and showed a significant correlation between Rab15 expression and neuronal differentiation. As aberrant alternative splicing is intimately associated with an increasing number of cancers, its use as a new diagnostic and/or prognostic biomarker has attracted considerable attention. In the present study, we explored cancer-associated changes of Rab15 alternative splicing in neuroblastoma TICs. We found that Rab15 alternative splicing generated two novel isoforms designated as Rab15 AN2 and Rab15 AN3 in addition to two known isoforms designated as Rab15 CN and Rab15
Introduction
Neuroblastoma is the most commonly diagnosed cancer in the first year of life, and accounts for approximately 15% of all cancer-related deaths in the pediatric population. Although outcomes in neuroblastoma patients have improved steadily over the last 30 years, 50-60% of high-risk neuroblastoma patients are estimated to experience relapse. Consequently, their overall survival rates remain less than 40% despite more aggressive therapies (1) (2) (3) . A growing body of evidence demonstrates that tumor-initiating cells (TICs) are present in most tumors and are responsible for sustaining tumor growth, progression, metastases and relapse (4) (5) (6) . While many tumors regress after treatments that target proliferating tumor cells, inherent resistance of TICs leads to tumor relapse (7) . Neuroblastoma TICs were recently identified as spheres grown in serum-free non-adherent culture used for neural crest stem cell growth and were shown to express stem cell markers, to have the ability to self-renew and differentiate into multiple cell types, and to form metastatic tumors in immunodeficient mice (8) .
Rab family small G proteins that constitute more than 60 members in humans play a key role in the spatiotemporal regulation of membrane traffic. Each Rab protein recognizes distinct subsets of intracellular membranes and controls the specific membrane transport pathways. Rab proteins function as a molecular switch cycling between 'inactive' GDP-bound and 'active' GTP-bound forms. The GTP-bound Rab protein interacts with their effector protein(s) that mediate the specific function of each Rab protein (9) (10) (11) (12) . In genomic amplicons of ovarian and breast cancers, Rab25 and its effector Rab-coupling protein (RCP), which regulate the endocytic recycling pathway, are identified as cancer driver genes (13, 14) . In melanoma, Rab27A that controls melanosome transport is implicated in cancer progression (15) . Rab15 was originally isolated as a brain-specific Rab protein regulating the endocytic recycling pathway and was recently identified as a downstream target of the neural basic helix-loop-helix (bHLH) transcription factor Atoh1 (16) (17) (18) . We previously identified two alternatively spliced Rab15 isoforms in neuroblastoma cells and showed the significant correlation between Rab15 expression and neuronal differentiation (19) . Alternative splicing produces multiple mRNAs from a single gene and represents the most prominent mechanism generating mRNA diversity. More than 90% of human genes undergo alternative splicing in a highly developmentand tissue-specific manner. Although the association between differential expressions of alternatively spliced isoforms and cancer progression are shown for only a handful of genes, the identification of an increasing number of cancer-associated alternative splicings has attracted considerable attention to use them as a new diagnostic and/or prognostic biomarker (20) (21) (22) . In the present study, we identified and characterized two novel Rab15 isoforms in spheres of neuroblastoma cells.
Materials and methods
Neuroblastoma cells. Human neuroblastoma BE(2)-C cells were obtained from ATCC (Manassas, VA). NBTT2D cells were previously described (19) . NBTT1 and NBTT3 cells were generated as previously described (19) . Briefly, tumor samples were obtained from patients with high-risk neuroblastoma who were admitted to Hyogo Children's Hospital and gave written informed consent approved by the Hyogo Children's Hospital Ethics Board. The samples were handled in accordance with the Guidelines for Clinical Research of Kobe University Graduate School of Medicine. Tumor tissue samples were collected, cut into 2-3 mm 3 pieces, enzymatically dissociated with Liberase DH (Roche, Mannheim, Germany) in PBS for 15-45 min at 37˚C followed by the addition of 10% FBS to inhibit enzyme activity, and filtered through a 100-µm cell strainer (BD Biosciences, Bedford, MA). The resulting tumor tissue cells were washed with PBS, cultured at 37˚C (5% CO 2 and 95% air) in complete medium consisting of Dulbecco's modified Eagle's medium (DMEM)/Ham's F12 (Wako Pure Chemical; Osaka, Japan) and 10% fetal bovine serum (FBS; Invitrogen, Carlsbad, CA).
Cell culture. Neuroblastoma cells were cultured at 37˚C (5% CO 2 and 95% air) in complete medium consisting of DMEM/ Ham's F12 (Wako Pure Chemical) and 10% FBS (Invitrogen) and subcultured by 0.25% trypsin-EDTA (Invitrogen). Phase-contrast images of parental cells were acquired using a BZ-9000E fluorescence microscope (Keyence, Osaka, Japan).
Sphere culture. Neuroblastoma spheres were cultured as previously described (23) . Briefly, neuroblastoma cells were cultured at 37˚C (5% CO 2 and 95% air) in sphere medium consisting of DMEM/Ham's F12 (3:1, Invitrogen), 100 units/ml penicillin/streptomycin (PC/SM; Invitrogen), 2% B27 supplement (Invitrogen), 40 ng/ml basic fibroblast growth factor (bFGF; R&D Systems, Minneapolis, MN), and 20 ng/ml epidermal growth factor (EGF; R&D Systems), subcultured by non-enzymatic cell dissociation solution (Sigma, St. Louis, MO), and maintained for >4 weeks in Ultra-low attachment culture dishes (CORNING, Corning, NY). Phase-contrast images of spheres were acquired using a BZ-9000E fluorescence microscope (Keyence).
cDNA cloning of novel alternatively spliced Rab15 isoforms.
Total RNA from spheres of BE(2)-C cells was isolated with the RNeasy Mini kit (Qiagen, Valencia, CA) and reverse transcribed using the PrimeScript II first strand cDNA Synthesis kit (Takara, Otsu, Japan). The full-length Rab15 CN cDNA was amplified by PCR using PrimeStar GXL DNA Polymerase (Takara) and cloned into pCMV6-AN-GFP (OriGene, Rockville, MD). The resulting plasmid DNAs from nine independent clones was sequenced using an ABI Prism 3100 Genetic Analyzer (Applied Biosystems, Foster City, CA AN2 , and Rab15 AN3 to PGK1 and Rab15 isoform balance were calculated by the comparative C T method. Primers for Rab15 CN (AB678453) were 5'-AGAGATACCAGACCATCACA-3' (sense) and 5'-TTCTGGTGCGTACTCATCCACGTC-3' (antisense), Rab15 AN1 (AB678452) were 5'-TACAGATCTGGGACAC TGCA-3' (sense) and 5'-CCGGCAGTGAGGTGGCATCT-3' (antisense), Rab15 AN2 (AB672631) were 5'-AGAGATACCAG ACCATCACA-3' (sense) and 5'-CCGTGGAGGCCTCATC CACGT-3' (antisense), Rab15 AN3 (AB672632) were 5'-AGAG ATACCAGACCATCACA-3' (sense) and 5'-GGTATCAGA GCTCATCCACGT-3' (antisense), and phosphoglycerate kinase 1 (PGK1, NM_000291) were 5'-GGAGAACCTCCG CTTTCAT-3' (sense) and 5'-GCTGGCTCGGCTTTAACC-3' (antisense).
Results

Identification of novel alternatively spliced Rab15 isoforms.
We previously identified two alternatively spliced Rab15 isoforms designated as Rab15 CN and Rab15 AN and showed that Rab15 isoform balance measured by the Rab15 CN /Rab15 AN ratio was significantly increased during neuronal differentiation of neuroblastoma cells (19) . As aberrant alternative splicing is intimately associated with an increasing number of cancers, its use as a new diagnostic and/or prognostic biomarker has attracted considerable attention. Therefore, we examined cancer-associated changes of Rab15 alternative splicing in spheres of neuroblastoma cells, in which TICs were highly enriched (8) . When BE(2)-C cells were cultured in a serumfree non-adherent condition, they efficiently formed spheres as previously described (23) (Fig. 1A) . To detect cancer-associated changes of Rab15 alternative splicing, we first cloned the fulllength Rab15 CN (AB678453) cDNA from spheres of BE (2) Here, we designated exon 4c-and exon 4d-inserted clones as Rab15 AN2 (AB672631) and Rab15 AN3 (AB672632), respectively. Accordingly, we re-designated Rab15 AN with a 627 bp ORF as Rab15 AN1 (AB678452) (Fig. 1B) .
Tissue distribution of Rab15 AN2 and Rab15
AN3
. As Rab15
AN2
and Rab15 AN3 contained premature termination codons that would cause the resulting mRNAs to be degraded by nonsense-mediated mRNA decay (NMD) (24,25), we examined whether they were also expressed in normal human tissues by a quantitative real-time RT-PCR using the Rab15 isoformspecific primers (Fig. 1B) . Rab15 AN2 and Rab15 AN3 were detected in normal human tissues and showed a distinct tissue distribution pattern (Fig. 2) . Rab15 AN2 was predominantly expressed in the brain and testis, while Rab15 AN3 was more specifically detected in the brain (Fig. 2) , with distinct tissue distribution in humans.
Rab15 alternative splicing in parental cells and spheres of BE(2)-C cells.
To analyze Rab15 alternative splicing in parental cells and spheres of BE(2)-C cells, we examined the expression of all Rab15 isoforms. In parental cells, Rab15 CN was the most prevalent isoform and was expressed 13.2-fold more highly than the second most prevalent isoform, Rab15 AN1 (Fig. 3A) . In spheres, Rab15 CN was also the most prevalent isoform but was only expressed 6.1-fold more than the second prevalent isoform Rab15 AN3 (Fig. 3B) , suggesting that Rab15 alternative splicing was considerably altered in spheres of BE (2) observation (19) , it was considerably varied, ranging from 0.6 in the testis to 4.3 in the heart (Fig. 4) , suggesting that Rab15 alternative splicing was subjected to the tissue-specific regulation.
Altered Rab15 isoform balance in spheres of neuroblastoma cells. As Rab15 isoform balance measured by the Rab15 CN / Rab15 AN1 ratio was significantly increased during neuronal differentiation of neuroblastoma cells (19) , we here examined the Rab15 isoform balance measured by the Rab15 CN / Rab15 AN1+AN2+AN3 ratio in parental cells and spheres of neuroblastoma cells. Because neuroblastoma cells displayed a considerable heterogeneity, we used three additional neuroblastoma cell lines designated as NBTT1, NBTT2D, and NBTT3 from high-risk patients in addition to BE(2)-C cells (Table I) . Compared to parental cells, Rab15 isoform balance was significantly decreased in spheres of all BE(2)-C, NBTT1, NBTT2D, and NBTT3 cells (Fig. 5) , suggesting that Rab15 alternative splicing was altered in spheres of neuroblastoma cells.
Discussion
In the present study, we found that Rab15 alternative splicing generated at least two novel isoforms in addition to two known isoforms and was altered in spheres of neuroblastoma cells. Neuroblastoma is believed to originate from neural crest cells that normally undergo sympathoadrenal differentiation (1-3). Although it is currently unclear whether neuroblastoma TICs arise directly from the normal neural crest cells or are derived from the de-differentiation of already transformed cells, TICs can be isolated as spheres (8) . As spheres and parental cells were enriched in TICs and non-TICs, Rab15 alternative splicing was likely altered during the differentiation of neuroblastoma TICs into non-TICs.
Transcriptional profiling of normal and cancer cells leads to the identification of an increasing number of cancer-associated alternative splicing in a variety of cancers. Although these alternative splicings may not play any significant role in cancer progression, the association between differential expression of alternatively spliced isoforms and cancer progression has been validated for several genes (20) (21) (22) . Aberrant expression of mouse double minute 2 (MDM2) isoforms is correlated with a poor prognosis in breast cancer (26) . Isoform balance The tumor risk group was based on the Children's Oncology Group Neuroblastoma Risk Stratification System (33). NBTT1 cells were derived from the same patient as the NBBM2 bone marrow cells described in our previous report (19) .
of hyaluronan synthase 1 (HAS1) and receptor for hyaluronanmediated motility (RHAMM) is shown to be a prognostic marker for multiple myeloma (27, 28) . In neuroblastoma, the expression of an alternatively spliced isoform of tumor suppressor p73, ∆Np73, is associated with reduced survival (29) . Furthermore, cyclooxygenase inhibitors were shown to downregulate ∆Np73 expression and induce the other p73 isoform, TAp73, providing a possible therapeutic way to modulate and/or correct cancer-associated alternative splicing (30) . In the case of Rab15, whether alternatively spliced isoforms Rab15
AN1
, Rab15 AN2 , and Rab15 AN3 have actual roles in neuroblastoma progression or are merely consequences of transformation is an open question for future study.
While we previously showed that Rab15 CN expression was correlated with neuronal differentiation of neuroblastoma cells (19) , Rab15 was recently identified as a downstream target of neural bHLH transcription factor Atoh1 that specified distinct neuronal subtypes of the proprioceptive pathway (18) . Atoh1 expression is known to control the normal development of the cerebellum and prevent medulloblastoma progression (31) . In neuroblastoma cells, Atoh1 expression is regulated by β-catenin expression (32) . It is tempting to speculate that the β-catenin-Atoh1-Rab15 system participates in some aspects of neuroblastoma progression. Together with our previous findings, the present study revealed that Rab15 isoform balance measured by the Rab15 CN /Rab15 AN1+AN2+AN3 ratio was significantly increased during differentiation of neuroblastoma cells, the differentiation of TICs into non-TICs as well as the neuronal differentiation (19) . Because prognosis of neuroblastoma correlates with the degree of differentiation, Rab15 isoform balance may deserve further evaluation as a new prognostic biomarker.
In summary, we identified four Rab15 isoforms, Rab15 CN , Rab15 AN1 , Rab15 AN2 , and Rab15
AN3
, in neuroblastoma cells, and demonstrated that Rab15 isoform balance measured by the Rab15 CN /Rab15 AN1+AN2+AN3 ratio was significantly decreased in spheres of neuroblastoma cells. The present study suggests that Rab15 alternative splicing may serve as a biomarker to discriminate TICs from non-TICs in neuroblastoma.
